annual accounts payable:
$45.66M+$8.97M(+24.46%)Summary
- As of today (May 21, 2025), ANIP annual accounts payable is $45.66 million, with the most recent change of +$8.97 million (+24.46%) on December 31, 2024.
- During the last 3 years, ANIP annual accounts payable has risen by +$22.69 million (+98.79%).
- ANIP annual accounts payable is now at all-time high.
Performance
ANIP Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$53.06M+$7.40M(+16.21%)Summary
- As of today (May 21, 2025), ANIP quarterly accounts payable is $53.06 million, with the most recent change of +$7.40 million (+16.21%) on March 31, 2025.
- Over the past year, ANIP quarterly accounts payable has increased by +$3.63 million (+7.34%).
- ANIP quarterly accounts payable is now -12.86% below its all-time high of $60.89 million, reached on September 30, 2024.
Performance
ANIP quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ANIP Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.5% | +7.3% |
| 3 y3 years | +98.8% | +140.5% |
| 5 y5 years | +212.6% | +325.0% |
ANIP Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.8% | -12.9% | +179.4% |
| 5 y | 5-year | at high | +305.4% | -12.9% | +371.2% |
| alltime | all time | at high | >+9999.0% | -12.9% | >+9999.0% |
ANIP Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $53.06M(+16.2%) |
| Dec 2024 | $45.66M(+24.5%) | $45.66M(-25.0%) |
| Sep 2024 | - | $60.89M(+25.1%) |
| Jun 2024 | - | $48.68M(-1.5%) |
| Mar 2024 | - | $49.43M(+34.7%) |
| Dec 2023 | $36.68M(+25.2%) | $36.68M(+7.6%) |
| Sep 2023 | - | $34.08M(+19.5%) |
| Jun 2023 | - | $28.50M(-12.8%) |
| Mar 2023 | - | $32.69M(+11.5%) |
| Dec 2022 | $29.30M(+27.6%) | $29.30M(+54.3%) |
| Sep 2022 | - | $18.99M(-31.3%) |
| Jun 2022 | - | $27.64M(+25.3%) |
| Mar 2022 | - | $22.06M(-4.0%) |
| Dec 2021 | $22.97M(+104.0%) | $22.97M(+99.5%) |
| Sep 2021 | - | $11.51M(-11.3%) |
| Jun 2021 | - | $12.98M(-5.8%) |
| Mar 2021 | - | $13.77M(+22.3%) |
| Dec 2020 | $11.26M(-22.9%) | $11.26M(-16.3%) |
| Sep 2020 | - | $13.46M(-5.3%) |
| Jun 2020 | - | $14.21M(+13.8%) |
| Mar 2020 | - | $12.48M(-14.5%) |
| Dec 2019 | $14.61M(+64.4%) | $14.61M(+33.4%) |
| Sep 2019 | - | $10.95M(+11.7%) |
| Jun 2019 | - | $9.81M(-6.7%) |
| Mar 2019 | - | $10.52M(+18.4%) |
| Dec 2018 | $8.88M(+144.7%) | $8.88M(+22.4%) |
| Sep 2018 | - | $7.26M(-8.7%) |
| Jun 2018 | - | $7.95M(+62.7%) |
| Mar 2018 | - | $4.89M(+34.6%) |
| Dec 2017 | $3.63M(+7.1%) | $3.63M(-37.6%) |
| Sep 2017 | - | $5.82M(+84.6%) |
| Jun 2017 | - | $3.15M(-34.1%) |
| Mar 2017 | - | $4.79M(+41.2%) |
| Dec 2016 | $3.39M(+64.0%) | $3.39M(-28.4%) |
| Sep 2016 | - | $4.73M(-4.7%) |
| Jun 2016 | - | $4.96M(+63.2%) |
| Mar 2016 | - | $3.04M(+47.1%) |
| Dec 2015 | $2.07M(-22.2%) | $2.07M(-21.5%) |
| Sep 2015 | - | $2.63M(+98.7%) |
| Jun 2015 | - | $1.32M(-42.1%) |
| Mar 2015 | - | $2.29M(-13.8%) |
| Dec 2014 | $2.65M(+85.7%) | $2.65M(-13.2%) |
| Sep 2014 | - | $3.06M(+76.7%) |
| Jun 2014 | - | $1.73M(-34.9%) |
| Mar 2014 | - | $2.66M(+86.1%) |
| Dec 2013 | $1.43M(+26.6%) | $1.43M(-31.5%) |
| Sep 2013 | - | $2.09M(+27.6%) |
| Jun 2013 | - | $1.63M(+894.4%) |
| Mar 2013 | - | $164.40K(-85.4%) |
| Dec 2012 | $1.13M | $1.13M(-43.7%) |
| Sep 2012 | - | $2.00M(-47.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $3.84M(+16.9%) |
| Mar 2012 | - | $3.28M(+4.2%) |
| Dec 2011 | $3.15M(-35.2%) | $3.15M(-47.9%) |
| Sep 2011 | - | $6.04M(-4.8%) |
| Jun 2011 | - | $6.35M(-25.3%) |
| Mar 2011 | - | $8.50M(+74.8%) |
| Dec 2010 | $4.86M(+99.3%) | $4.86M(+7.5%) |
| Sep 2010 | - | $4.52M(-4.2%) |
| Jun 2010 | - | $4.72M(+17.9%) |
| Mar 2010 | - | $4.00M(+64.0%) |
| Dec 2009 | $2.44M(-23.3%) | $2.44M(-30.9%) |
| Sep 2009 | - | $3.53M(+38.4%) |
| Jun 2009 | - | $2.55M(+5.0%) |
| Mar 2009 | - | $2.43M(-23.7%) |
| Dec 2008 | $3.18M(+347.8%) | $3.18M(-7.0%) |
| Sep 2008 | - | $3.42M(+30.5%) |
| Jun 2008 | - | $2.62M(+13.8%) |
| Mar 2008 | - | $2.30M(+223.8%) |
| Dec 2007 | $710.60K(+14.3%) | $710.60K(+27.0%) |
| Sep 2007 | - | $559.40K(-37.1%) |
| Jun 2007 | - | $888.80K(+38.1%) |
| Mar 2007 | - | $643.80K(+3.5%) |
| Dec 2006 | $621.80K(-45.4%) | $621.80K(+95.4%) |
| Sep 2006 | - | $318.30K(-52.5%) |
| Jun 2006 | - | $669.70K(-51.5%) |
| Mar 2006 | - | $1.38M(+21.1%) |
| Dec 2005 | $1.14M(-2.5%) | $1.14M(+119.8%) |
| Sep 2005 | - | $518.50K(-33.7%) |
| Jun 2005 | - | $782.50K(-25.7%) |
| Mar 2005 | - | $1.05M(-9.9%) |
| Dec 2004 | $1.17M(+389.7%) | $1.17M(+36.5%) |
| Sep 2004 | - | $856.10K(+40.7%) |
| Jun 2004 | - | $608.30K(+61.9%) |
| Mar 2004 | - | $375.80K(+57.4%) |
| Dec 2003 | $238.70K(-49.3%) | $238.70K(-12.1%) |
| Sep 2003 | - | $271.70K(-43.3%) |
| Jun 2003 | - | $478.80K(+93.2%) |
| Mar 2003 | - | $247.80K(-47.4%) |
| Dec 2002 | $470.90K(+419.2%) | $470.90K(-10.9%) |
| Sep 2002 | - | $528.70K(+84.1%) |
| Jun 2002 | - | $287.20K(+101.5%) |
| Mar 2002 | - | $142.50K(+57.1%) |
| Dec 2001 | $90.70K(+102.9%) | $90.70K(-9.3%) |
| Sep 2001 | - | $100.00K(-48.4%) |
| Jun 2001 | - | $193.70K(+108.1%) |
| Mar 2001 | - | $93.10K(+108.3%) |
| Dec 2000 | $44.70K(-41.3%) | $44.70K(-34.2%) |
| Sep 2000 | - | $67.90K(-38.8%) |
| Jun 2000 | - | $111.00K(+10.0%) |
| Mar 2000 | - | $100.90K |
| Dec 1999 | $76.10K(+10.6%) | - |
| Dec 1998 | $68.80K | - |
FAQ
- What is ANI Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual accounts payable year-on-year change?
- What is ANI Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly accounts payable year-on-year change?
What is ANI Pharmaceuticals annual accounts payable?
The current annual accounts payable of ANIP is $45.66M
What is the all time high annual accounts payable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual accounts payable is $45.66M
What is ANI Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ANIP annual accounts payable has changed by +$8.97M (+24.46%)
What is ANI Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ANIP is $53.06M
What is the all time high quarterly accounts payable for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly accounts payable is $60.89M
What is ANI Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ANIP quarterly accounts payable has changed by +$3.63M (+7.34%)